GSTM1 and chronic kidney disease: In a study with chronic kidney disease patients, parenteral iron supplementation was compared with oral liposomal iron and it was seen that with eight weeks of therapy, liposomal iron group had significant increase in serum Hb from baseline while the other group did not have significant rise in serum Hb [18].